Tag: ACC 2023

Elevated hs-cTnL levels precede and predict pre-eclampsia

Key Points: There have been limited data regarding the biomarkers that may…

TEER for degenerative MR Safe, Effective: a real world analysis using the STS/ACC TVT registry

Key Points While transcatheter edge-to-edge repair (TEER) is FDA approved for treatment…

STREAM-2 Trial: Half-dose TNK + PCI Provides Effective reperfusion In Elderly STEMI Patients

Key Points: Pharmaco-invasive (PI) strategy with half-dose tenecteplase (TNK) is compared to…

Electronically Delivered Nudges Increase Influenza Vaccination Uptake: The NUDGE-FLU Trial

Key Points Despite the proven benefits of annual influenza (flu) vaccination among…

RAPID HF: Rate-adaptive atrial pacing for HFpEF not ready for prime time

Key Points Over half of the patients with HFpEF suffer from exercise…

PCDS Statin: Automated reminders increase statin use in ASCVD patients

Key Points Despite guideline recommendations, both statin use overall and high intensity…

BETTER CARE-HF: EHR-embedded alert increased MRA prescription in AMBULATORY HFrEF patients

Key Points Many patients with heart failure with reduced ejection fraction (HFrEF)…

TAVR at 3 years showed durable benefits vs surgery: the Evolut Low Risk Trial

Key Points Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve…

FLAME: FlowTriever use for PE associated with decreased in-hospital adverse outcomes

Key Points: Mortality in high-risk PE remains unacceptably high (25%) despite advances…

Intravascular Imaging-Guiding PCI in Complex Coronary Lesions Linked to Better Outcomes: The RENOVATE-COMPLEX-PCI Study

Key Points: Intravascular imaging-guided PCI shows promise in improving outcomes for patients…

TARGET Trial: On-site CT-FFR Feasible and Effective in stable CAD

Key points: The TARGET trial is the first randomized trial designed to…

BIOVASC Trial: Immediate complete revascularization non-inferior to staged complete in MVD ACS patients

Key Points: Complete revascularization is recommended in patients with multivessel CAD who…

HALO – Baxdrostat Fails to Beat Placebo for Blood Pressure Reduction in Uncontrolled Hypertension

Key Points Baxdrostat, a highly selective aldosterone synthase inhibitor, reduced systolic blood…

Evolocumab Effect on Plaque Characteristics in Stable CAD Patients

Key Points The YELLOW III study aimed to assess the effect of…

No difference in Heart Failure Outcomes with Advanced Imaging modalities vs SPECT: The AIMI-HF Trial

Key Points: Imaging may be underused in patients with ischemic heart failure…

Viability Not Linked to Survival or LV improvement: The REVIVED-BCIS2 Randomized Trial

Key Points: -It is unclear whether myocardial viability tests should be used…

Atorvastatin Reduced Left Ventricular Dysfunction From Anthracyclines: The STOP-CA Trial

  Key Points -Anthracycline therapy is associated with the development of heart…